Performance of NVCR Novocure | -78.3% in 12m
Compare NVCR with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Novocure with its related Sector/Index XLV
Performance Duell NVCR vs XLV
| TimeFrame | NVCR | XLV |
|---|---|---|
| 1 Day | 4.16% | 0.25% |
| 1 Week | 15.5% | 0.28% |
| 1 Month | 7.57% | -1.67% |
| 3 Months | 7.65% | -0.77% |
| 6 Months | 14.8% | 10.69% |
| 12 Months | -78.3% | 7.15% |
| YTD | 2.64% | 1.84% |
| Rel. Perf. 1m | -0.06 | |
| Rel. Perf. 3m | -0.08 | |
| Rel. Perf. 6m | -0.60 | |
| Rel. Perf. 12m | -16.22 |
Is Novocure a good stock to buy?
No, based on ValueRay Fundamental Analyses, Novocure (NASDAQ:NVCR) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -68.90 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NVCR as of May 2024 is 13.57. This means that NVCR is currently overvalued and has a potential downside of -8.19% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NVCR as of May 2024 is 13.57. This means that NVCR is currently overvalued and has a potential downside of -8.19% (Sold with Premium).
Is NVCR a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
Values above 0%: NVCR is performing better - Values below 0%: NVCR is underperforming
Compare NVCR with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 15.23% | 8.95% | -3.44% | -104.04% |
| US NASDAQ 100 | QQQ | 14.84% | 8.70% | -3.65% | -114.11% |
| US Dow Jones Industrial 30 | DIA | 14.70% | 8.06% | 0.28% | -95.42% |
| German DAX 40 | DBXD | 16.15% | 8.51% | -3.95% | -90.71% |
| UK FTSE 100 | ISFU | 14.66% | 3.97% | 0.80% | -87.09% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 13.66% | 3.55% | 12.27% | -67.70% |
| Hongkong Hang Seng | HSI | 11.41% | -0.62% | 16.29% | -63.72% |
| Japan Nikkei 225 | EXX7 | 13.74% | 10.55% | 0.01% | -96.98% |
| India NIFTY 50 | INDA | 15.09% | 6.21% | -4.58% | -105.95% |
| Brasil Bovespa | EWZ | 13.71% | 6.00% | 10.27% | -97.54% |
NVCR Novocure vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 14.17% | 10.37% | -4.91% | -117.13% |
| Consumer Discretionary | XLY | 16.63% | 8.09% | 3.41% | -100.15% |
| Consumer Staples | XLP | 15.40% | 5.48% | 2.90% | -79.53% |
| Energy | XLE | 19.43% | 13.19% | 4.81% | -97.71% |
| Financial | XLF | 15.99% | 10.02% | -6.70% | -106.00% |
| Health Care | XLV | 15.19% | 9.24% | 4.06% | -85.49% |
| Industrial | XLI | 16.04% | 9.88% | -7.45% | -103.79% |
| Materials | XLB | 16.29% | 11.06% | -0.66% | -93.04% |
| Real Estate | XLRE | 15.06% | 11.11% | 5.98% | -80.75% |
| Technology | XLK | 14.54% | 9.46% | -2.86% | -113.36% |
| Utilities | XLU | 13.50% | 2.58% | 1.91% | -80.85% |
| Aerospace & Defense | XAR | 13.90% | 6.46% | -1.76% | -102.42% |
| Biotech | XBI | 10.25% | 7.79% | -14.03% | -83.75% |
| Homebuilder | XHB | 14.76% | 10.67% | -23.39% | -128.26% |
| Retail | XRT | 15.17% | 9.24% | -5.32% | -100.10% |
Does Novocure outperform its market, is NVCR a Sector Leader?
No, over the last 12 months Novocure (NVCR) made -78.34%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.15%.
Over the last 3 months NVCR made 7.65%, while XLV made -0.77%.
No, over the last 12 months Novocure (NVCR) made -78.34%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.15%.
Over the last 3 months NVCR made 7.65%, while XLV made -0.77%.
| Period | NVCR | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 7.57% | -1.67% | -1.38% |
| 3 Months | 7.65% | -0.77% | 4.13% |
| 12 Months | -78.34% | 7.15% | 25.70% |